Kazatomproms Q3 Output Surges 17 Highlighting Uranium Supply Dynamics Nabtesco Targets EV Bus Market With AllElectric Power Steering Mass Production The Mandalorian Grogu Opens to Lowest Projected Debut Among Disney Star Wars Films Social Security Claiming Strategies Weighing Early Benefits vs Survivors Benefit for a 62YearOld AnalystFavored Stocks Show Strong Earnings Growth Potential Five Below Fabrinet Alamos Gold Among Seven Picks Nvidia Earnings Set to Test Market Sentiment as Investors Focus on China Strategy and Political Commentary STRRP Q1 2026 Earnings Significant EPS Miss Triggers Stock Decline MHO Q1 2026 Earnings EPS Slightly Beats Estimate Stock Holds Steady UGI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher LITS Q4 2024 Earnings Significant EPS Miss Raises Concerns Amid Lack of Revenue Disclosure Saratoga Investment Corp 8125 Notes due 2027 SAY Q1 2026 Earnings Steep EPS Miss Weighs on Sentiment Despite Modest Price Recovery United Community Banks Inc UCB Q1 2026 Earnings Slight Earnings Miss Meets Modest Share Price Uptick Indigo Acquisition Corp Unit INACU Holds Steady at 1028 as SPAC Units Trade in Tight Range Atlas Critical Minerals Corporation ATCX Edges Higher Amid Sector Momentum Japer Therapeutics Warrants JSPRW Hold Steady at 001 as Traders Eye Catalysts Aurora Innovation Inc AUR Edges Lower as Key Support Level Approaches Mega Matrix Inc MPU Plunges 21 Approaches Key Support at 040 Rail Vikas Nigam Q4 FY26 Net Profit Drops 59 Despite Revenue Growth Final Dividend Announced CLF Q1 2026 Earnings Earnings Miss Amid Persistent Steel Market Headwinds DMO Edges Higher Western Asset Mortgage Opportunity Fund Shows Modest Gains Kochav Defense Acquisition Corp KCHV Holds Steady Near 1034 Amid SPAC Stability Six Flags Entertainment FUN Edges Higher as Stock Nears Key Resistance Zone Liberty Broadband LBRDA Slips 267 as Selling Pressure Intensifies Near Key Support Horizon Space Acquisition II Corp HSPT Slips 759 as Selling Pressure Intensifies Strive Inc ASST Slips 204 as Shares Test Key Support Near 1684 Haemonetics HAE Surges 573 to 6549 Testing Key Resistance Levels PDS Biotechnology PDSB Edges Higher by 182 as Biotech Speculative Interest Persists